G L Klerman. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acridines/therapeutic useAdministration, OralAntipsychotic Agents/therapeutic useButyrophenones/administration & dosageButyrophenones/therapeutic useCentral Nervous System Diseases/chemically inducedDopamine/metabolismHumansMolindone/therapeutic usePhenothiazinesPhytotherapyPiperazines/therapeutic usePlants, MedicinalRauwolfia/administration & dosageRauwolfia/therapeutic useSchizophrenia/diagnosisSchizophrenia/drug therapySchizophrenia/epidemiologySeizures/chemically inducedStructure-Activity RelationshipTetrabenazine/therapeutic useThioxanthenes/administration & dosageThioxanthenes/therapeutic useTranquilizing Agents/administration & dosageTranquilizing Agents/adverse effectsTranquilizing Agents/therapeutic useVitamin B 12/administration & dosage
Substances: See more » AcridinesAntipsychotic AgentsButyrophenonesPhenothiazinesPiperazinesThioxanthenesTranquilizing AgentsVitamin B 12MolindoneDopamineTetrabenazine
Year: 1974 PMID: 4152997 DOI: 10.1146/annurev.me.25.020174.001215
Source DB: PubMed Journal: Annu Rev Med ISSN: 0066-4219 Impact factor: 13.739